PAM
MRNA icon

Panagora Asset Management’s Moderna MRNA Stock Holding History

Panagora Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.26M Buy
103,601
+61,076
+144% +$3.16M 0.02% 392
2026
Q1 		$2.16M Sell
42,525
-2,233
-5% -$104K 0.01% 568
2025
Q4 		$1.32M Sell
44,758
-265
-0.6% -$7.2K ﹤0.01% 646
2025
Q3 		$1.16M Buy
+45,023
New +$1.26M ﹤0.01% 629
2024
Q4 		– Sell
-5,431
Closed -$363K – 1214
2024
Q3 		$363K Sell
5,431
-2
-0% -$184 ﹤0.01% 999
2024
Q2 		$645K Sell
5,433
-3,348
-38% -$424K ﹤0.01% 853
2024
Q1 		$936K Sell
8,781
-5
-0.1% -$504 ﹤0.01% 823
2023
Q4 		$874K Sell
8,786
-1,730
-16% -$146K ﹤0.01% 856
2023
Q3 		$1.09M Buy
10,516
+3,392
+48% +$378K 0.01% 759
2023
Q2 		$866K Buy
7,124
+1,634
+30% +$218K 0.01% 834
2023
Q1 		$843K Sell
5,490
-2,812
-34% -$464K 0.01% 905
2022
Q4 		$1.49M Sell
8,302
-3,074
-27% -$503K 0.01% 726
2022
Q3 		$1.34M Sell
11,376
-47
-0.4% -$7.13K 0.01% 745
2022
Q2 		$1.63M Sell
11,423
-734
-6% -$105K 0.01% 689
2022
Q1 		$2.09M Sell
12,157
-5,698
-32% -$959K 0.01% 668
2021
Q4 		$4.54M Sell
17,855
-51,406
-74% -$15M 0.02% 426
2021
Q3 		$26.7M Sell
69,261
-18,953
-21% -$6.99M 0.14% 154
2021
Q2 		$20.7M Sell
88,214
-1,133
-1% -$202K 0.11% 189
2021
Q1 		$11.7M Sell
89,347
-50,792
-36% -$7.36M 0.07% 280
2020
Q4 		$14.6M Buy
140,139
+85,347
+156% +$8.63M 0.09% 211
2020
Q3 		$3.88M Buy
54,792
+53,924
+6,212% +$3.76M 0.02% 456
2020
Q2 		$56K Buy
+868
New +$47.5K ﹤0.01% 1947

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Panagora Asset Management's MRNA Position: Q2 2026 in Review

Panagora Asset Management increased its Moderna (MRNA) stake by 144% in Q2 2026, buying an estimated $3.16M and bringing the position to 103,601 shares worth $7.26M. The position accounts for 0.02% of the portfolio, ranked #392.

Panagora Asset Management first reported a position in MRNA in Q2 2020 and has held it in 22 quarters since. The position peaked at $26.7M in Q3 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Panagora Asset Management held 103,601 shares of Moderna worth $7.26M as of Q2 2026.
  • Panagora Asset Management bought 61,076 Moderna shares in Q2 2026, an estimated $3.16M.
  • Moderna made up 0.02% of Panagora Asset Management's portfolio in Q2 2026, its #392 holding.
  • Panagora Asset Management first reported a position in Moderna in Q2 2020 and has held it in 22 quarters since.
  • Panagora Asset Management's Moderna position peaked at $26.7M in Q3 2021.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.